These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


115 related items for PubMed ID: 1642962

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Relevance of intravenous cocaine use in relation to prevalence of HIV, hepatitis B and C virus markers among intravenous drug abusers in southern Italy.
    Guadagnino V, Zimatore G, Izzi A, Caroleo B, Rocca A, Montesano F, Costa C, Masciari R, Naso E, Biselli R.
    J Clin Lab Immunol; 1995; 47(1):1-9. PubMed ID: 8735431
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention.
    Koester S, Glanz J, Barón A.
    AIDS Behav; 2005 Mar; 9(1):27-39. PubMed ID: 15812611
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Needle-sharing among young IV drug users and their social network members: The influence of the injection partner's characteristics on HIV risk behavior.
    Unger JB, Kipke MD, De Rosa CJ, Hyde J, Ritt-Olson A, Montgomery S.
    Addict Behav; 2006 Sep; 31(9):1607-18. PubMed ID: 16459023
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prevalence and correlates of indirect sharing practices among young adult injection drug users in five U.S. cities.
    Thiede H, Hagan H, Campbell JV, Strathdee SA, Bailey SL, Hudson SM, Kapadia F, Garfein RS, DUIT Study Team.
    Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S39-47. PubMed ID: 17466464
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
    Vicknasingam B, Narayanan S, Navaratnam V.
    Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
    [Abstract] [Full Text] [Related]

  • 12. HIV diagnoses among injection-drug users in states with HIV surveillance--25 states, 1994-2000.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2003 Jul 11; 52(27):634-6. PubMed ID: 12855944
    [Abstract] [Full Text] [Related]

  • 13. Risk of human immunodeficiency virus infection among pregnant crack cocaine users in a rural community.
    Ellerbrock TV, Harrington PE, Bush TJ, Schoenfisch SA, Oxtoby MJ, Witte JJ.
    Obstet Gynecol; 1995 Sep 11; 86(3):400-4. PubMed ID: 7651651
    [Abstract] [Full Text] [Related]

  • 14. Incidence and risk factors of HIV infection: a prospective study of seronegative drug users from Milan and northern Italy, 1987-1989.
    Nicolosi A, Musicco M, Saracco A, Molinari S, Ziliani N, Lazzarin A.
    Epidemiology; 1990 Nov 11; 1(6):453-9. PubMed ID: 2090283
    [Abstract] [Full Text] [Related]

  • 15. Factors associated with client-reported HIV infection among clients entering methadone treatment.
    MacGowan RJ, Fichtner RR, Swanson N, Collier C, Kroliczak A, Cole G.
    AIDS Educ Prev; 1997 Jun 11; 9(3):205-17. PubMed ID: 9241388
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003.
    Emmanuelli J, Desenclos JC.
    Addiction; 2005 Nov 11; 100(11):1690-700. PubMed ID: 16277629
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Associations between HIV-related injection behaviour and distance to and patterns of utilisation of syringe-supply programmes.
    Bruneau J, Daniel M, Kestens Y, Zang G, Généreux M.
    J Epidemiol Community Health; 2008 Sep 11; 62(9):804-10. PubMed ID: 18701731
    [Abstract] [Full Text] [Related]

  • 20. Psychoeducational group approach: HIV risk reduction in drug users.
    Sorensen JL, London J, Heitzmann C, Gibson DR, Morales ES, Dumontet R, Acree M.
    AIDS Educ Prev; 1994 Apr 11; 6(2):95-112. PubMed ID: 8018443
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.